Nalaganje...
SHP2: a new target for pro-senescence cancer therapies
Cellular senescence is a response to stress that disables cell proliferation and orchestrates an inflammatory process that eliminates damaged cells. The first pro-senescence drugs for cancer treatment are now a clinical reality, but still few targets have been identified whose inactivation results i...
Shranjeno v:
| izdano v: | EMBO J |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BlackWell Publishing Ltd
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4474521/ https://ncbi.nlm.nih.gov/pubmed/25916826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201591616 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|